Can you take Cortexin and Semax together?

There is no specific, well-documented interaction rule for combining Cortexin and Semax in the aggregated research reviewed. Combining peptides should only be considered under professional supervision. This is not medical advice.

Which is better researched, Cortexin or Semax?

Cortexin is currently research-stage and Semax is investigational (in trials). "Better researched" depends on your research goal — review each profile's cited sources.

Nootropic & Cognitive · Comparison

Cortexin vs Semax

Q: What is the difference between Cortexin and Semax?

Cortexin: Polypeptide nootropic extracted from the cortex of cattle or pigs, containing a mixture of low-molecular-weight neuropeptides (≤10 kDa). Registered pharmaceutical in Russia and widely used in Eastern European clinical medicine for stroke recovery, traumatic brain injury, cognitive decline, epilepsy, and cerebrovascular disease. Decades of Russian clinical literature support neuroprotective and neurorestorative effects. Semax: Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH) — specifically the 4–7 fragment modified with a C-terminal Pro-Gly-Pro extension for stability. Developed in Russia in the 1980s and used clinically there for stroke recovery, cognitive enhancement, and neuroprotection, it is one of the most researched nootropic peptides with a decades-long safety record in Eastern European clinical practice. Its primary mechanism involves potent upregulation of BDNF (Brain-Derived Neurotrophic Factor). Both are in the Nootropic & Cognitive category but differ in mechanism, dosing, and research evidence — see the full comparison.

A neutral, side-by-side comparison of two nootropic & cognitive peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

Cortexin

Research-stage

Polypeptide nootropic extracted from the cortex of cattle or pigs, containing a mixture of low-molecular-weight neuropeptides (≤10 kDa). Registered pharmaceutical in Russia and widely used in Eastern European clinical medicine for stroke recovery, traumatic brain injury, cognitive decline, epilepsy, and cerebrovascular disease. Decades of Russian clinical literature support neuroprotective and neurorestorative effects.

Full profile

Semax

Investigational (in trials)

Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH) — specifically the 4–7 fragment modified with a C-terminal Pro-Gly-Pro extension for stability. Developed in Russia in the 1980s and used clinically there for stroke recovery, cognitive enhancement, and neuroprotection, it is one of the most researched nootropic peptides with a decades-long safety record in Eastern European clinical practice. Its primary mechanism involves potent upregulation of BDNF (Brain-Derived Neurotrophic Factor).

Full profile

	Cortexin	Semax
Category	Nootropic & Cognitive	Nootropic & Cognitive
Also known as	cortexin polypeptide, cortexin-10, neuropeptide bioregulator, cortexin-5	ACTH(4-7)PGP, Met-Glu-His-Phe-Pro-Gly-Pro
Evidence	Research-stage	Investigational (in trials)
Dosing range	5mg–20mg mg, daily IM injection for 10-day courses	200mcg–900mcg mcg, Once or twice daily (intranasal most common)
Administration	Intramuscular injection	Intranasal (preferred — high CNS bioavailability), Subcutaneous injection
Key side effects	Injection site pain, Rare allergic reaction, Headache (transient), Mild dizziness	Mild anxiety or restlessness at high doses, Nasal irritation (intranasal route), Increased energy / difficulty sleeping if dosed too late in the day, Mild appetite suppression
Cited sources	2 references	3 references

Key differences

Evidence level differs: Cortexin is research-stage, while Semax is investigational (in trials).
Administration: Cortexin — Intramuscular injection; Semax — Intranasal (preferred — high CNS bioavailability), Subcutaneous injection.
Dosing units differ: Cortexin is dosed in mg, Semax in mcg — they operate at different scales.
Frequency: Cortexin is typically daily IM injection for 10-day courses; Semax is Once or twice daily (intranasal most common).
Research depth: this profile cites 2 sources for Cortexin vs 3 for Semax.

How each works

Cortexin

Cortexin's multi-component neuropeptide mixture modulates neurotransmitter systems, improves cerebral blood flow, enhances neuroplasticity (BDNF upregulation), and exhibits antioxidant and anti-apoptotic activity in neuronal tissue. Russian stroke rehabilitation trials show improved neurological deficit scores and functional recovery with 10-day cortexin courses compared to standard care alone. The mechanism involves multiple parallel neuropeptide signaling pathways.

Semax

Semax increases BDNF expression in the hippocampus and frontal cortex by 1.3–1.6x at research doses in rodent models. It also upregulates NGF (nerve growth factor) and modulates serotonin, dopamine, and NMDA receptor systems. Russian clinical data (not yet replicated in Western trials) suggests efficacy in ischemic stroke recovery, ADHD, glaucoma, and cognitive decline. The Pro-Gly-Pro C-terminal extension dramatically improves resistance to enzymatic degradation compared to native ACTH(4-7).

Read the full Cortexin profile Read the full Semax profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.